Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Volume is still too light.. I want to see a confirmation move before I ever consider buying more. Most of us in here are already long the stock..
Benda are late in their 10k filing. It's not always a bad sign, but it is sometimes. I would not encourage anybody to buy here at .03, 04, or .05
These Pinkie chat rooms are really funny. This stock undergoes a symbol alteration and not a peep from anyone. I drops to 3 cents a share, still no comments. Yesterday, it jumps to 5 cents at the EOD, mum's the word. Today the bid is 5 and the ask is already at 7, please someone share some insight with us less worldly traders!
They will file their 10K.
What is going to happen?
Should happen between now and 4/15, according to the NT 10K and Mr. Yiqing Wan.
I am really looking forward to it.
;)
Yup, holding all mine here, someone is accumulating this fo sho...
Hey, that's the 52-week high. :)
Barcharts likes this too.
http://quote.barchart.com/texpert.asp?sym=BPMA
BPMA .119:)
and even some 10's. Nice.
;)
BPMA being majorly accumulated here..someone buying all they can get and holding...
Patent's don't seem to mean too much in China, besides if your about to follow Ted Kennedy, they really don't matter ar all!
The only problem is that the patent for Gendicine is in question, which I posted a link to several months ago. I'm not sure if it even matters at this point.
No wonder Pope is trying to lock down control of this company! With such a sweeping change in the treatment of most tumors, especially in-operable head tumors, this could be BueCue bucks! I wonder why this info hasn't made its way into western publications yet though?
http://translate.googleusercontent.com/translate_c?hl=en&ie=UTF-8&sl=zh-CN&tl=en&u=http://www.sibiono.com/zh-CN/news.html%3FnewsID%3D209655&prev=_t&rurl=translate.google.com&twu=1&usg=ALkJrhimSjGBvWgEho9ndPlaFjjygTTvMg
http://translate.googleusercontent.com/translate_c?hl=en&ie=UTF-8&sl=zh-CN&tl=en&u=http://www.sibiono.com/zh-CN/news.html%3FnewsID%3D209668&prev=_t&rurl=translate.google.com&twu=1&usg=ALkJrhjKjOYt2f2dpK3sxxn0sP9wkjEhHw
http://translate.googleusercontent.com/translate_c?hl=en&ie=UTF-8&sl=zh-CN&tl=en&u=http://www.sibiono.com/zh-CN/news.html%3FnewsID%3D209659&prev=_t&rurl=translate.google.com&twu=1&usg=ALkJrhinDO4bMvArHWzOm0iZIOCpbZaS9w
http://translate.googleusercontent.com/translate_c?hl=en&ie=UTF-8&sl=zh-CN&tl=en&u=http://www.sibiono.com/zh-CN/news.html%3FnewsID%3D209655&prev=_t&rurl=translate.google.com&twu=1&usg=ALkJrhimSjGBvWgEho9ndPlaFjjygTTvMg
http://translate.googleusercontent.com/translate_c?hl=en&ie=UTF-8&sl=zh-CN&tl=en&u=http://www.sibiono.com/zh-CN/news.html%3FnewsID%3D183536&prev=_t&rurl=translate.google.com&twu=1&usg=ALkJrhgZqL02XFPR-Rw3BAsbw_RdmMiosg
http://geoinvesting.com/companies/bpma_benda_pharmaceuticals_inc/research/investor_alert/0023982
http://geoinvesting.com/companies/bpma_benda_pharmaceuticals_inc/research/research/0023981
Witholding information from an IHub chat room is a "first born child" offence!
Would you be arrested or shot if you were to share whatever hotness you're keeping secret?
lol
While things are not perfect for this company, it still seems way undervalued, and I chose this stock in January as my stock of the year. We shall see! Lookin' good so far.
;)
I think I found something hot......... really hot.
But I have to keep it to myself. sorry guys. if this keeps going, i would reload
We need an update from the company about what is going on...anyone have a contact e-mail? thnx
Generally, "Benda Pharmaceutical, Inc. (Benda) is a pharmaceutical company that identifies, discovers, develops and manufactures both conventional medications and traditional chinese medicines (TCMs) for the treatment of some of common ailments and diseases (common cold, diabetes, cancer). The Company also develops and manufactures gene therapy products. The Company operates through its wholly owned subsidiary, Ever Leader Holdings Limited (Ever Leader). Benda sells generics to medical wholesalers for resale to hospitals. The Company sells its over the counter (OTC) medicines to wholesalers specializing in selling to retail chain drug stores. Its active pharmaceutical ingredients (APIs) are sold to large drug manufacturers under long-term supply contracts. The bulk chemicals are purchased by other Chinese drug companies."
i've got no clue but this 10q is unreal for the pps being down here
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=6909139
This is huge budd; do they have any products in the pipeline?
my small buy at .10 and average down at .02 not looking so bad anymore! muahaha. I wonder where this thing is headed...
BPMA .06 falling here
I know Pope owns the majority.. maybe they're buying.
They're trying to push them into liquidation, so if they're buying, maybe these shares are worth something.
I hope not f*ing pumpers...been holding this and adding since way before them douchebags started pumping this just cuz' this company's 10q is unreal for down here....JMO of course:)
It's probably them buying it
laugh out loud
Maybe we can get the gang from DFW Investments to run this thing again...Stace where are U? Please bring along your penny pumpin' friend, Layla.
ATTENTION:
BPMA getting some volume..
*knockknock*
Is this thing on?
8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: (Date of earliest event reported)
December 30, 2009
BENDA PHARMACEUTICAL, INC.
(Exact name of registrant as specified in charter)
Delaware
(State or other Jurisdiction of Incorporation or Organization)
000-16397
Taibei Mingju, 4th Floor,
6 Taibei Road, Wuhan, Hubei Province, 430015, PRC
41-2185030
(Commission File Number)
(Address of Principal Executive Offices and zip code)
(IRS Employer Identification No.)
+86 (27) 85494916
(Registrant's telephone
number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On December 30, 2009, we were served with a Summons and Complaint filed by Pope Investments, LLC (“Pope”) in the Court of Chancery of the State of Delaware (the “Court”) against the Company and our officers and directors. Pope filed the Summons and Complaint as a judgment creditor and as a shareholder of the Company. Pope alleges that the assets and profits of our subsidiary company have been wrongfully diverted by our officers and directors and requests the appointment of a receiver to liquidate and wind down the business affairs of the Company. In connection with the filing of the Summons and Complaint, Pope has also filed a motion for a Preliminary Injunction Motion seeking to enjoin the Company and our officers and directors from taking any further actions to divert the corporate assets and profits of our subsidiary company and for expedited discovery proceedings. Pope further requests the imposition of a constructive trust, an accounting, damages for an alleged breach of fiduciary duty by the Company’s officers and directors, and attorney fees.
Item 9.01 Financial Statement and Exhibits.
(d)
EXHIBITS
None.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
BENDA PHARMACEUTICAL, INC.
Date: January 12, 2010
By:
/s/ Yiqing Wan
Yiqing Wan
President
BPMA getting a little life today .03 x .035
Still loading on the dips here...this company has around 60 million+ in assets and about 30+ in liabilities...And they have millions in revenues every quarter..One of these days the company is going to PR and KABBOOMMMM...Most undervalued company on the OTCBB IMO
This stock seems extremely undervalued. According to the last 10Q, BV is around $1.24. They have not been diluting and revenues are healthy...seems like a no-brainer for 2010!
Nice eod action on price....
When volume does return, kaboom for sure!!!! imo
~J
yep,lol...one of these days though we will get a PR and we will KABOOM IMO...
Seller is still here...guess he needs drinking money for tonight.
Nice dude...holding long here and buying on these silly dips...
10Q was released today, lets see what happens....
~J
yup an update or big volume day could move this huge IMO....
Same here.... :)
Slow & steady increase works for me!
~J
Been waiting... ;o)
stock trying to make a move today, .03 x .05
so much volume today!!!
Looks like a nice entry point to load some more right here.
Followers
|
11
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
643
|
Created
|
08/26/07
|
Type
|
Free
|
Moderators |
On May 21, Benda Pharma (BPMA.OB) reported revenue of $3 million for Q1 of 2007, a decrease of 17% from the year-earlier period. Benda blamed the decrease on a temporary closing of its bulk chemical plant, a closing undertaken at the behest of the Chinese government, which mandated a cleanup of the wastewater of the plant. The plant is scheduled to be back online in August of this year.
Net income dropped to $0.4 million for the quarter, a decline of 51%. Besides the plant closing, Benda said it encountered additional expenses associated with being a public company. Benda has 96.3 million shares outstanding and, at its current price of $1.70 per share, it has a market capitalization of $164 million.
Benda is involved in making western and Traditional Chinese Medications, and it manufactures active pharmaceutical ingredients.
Quote:
http://www.bendapharma.com/stockquote.cfm
http://www.stockcharts.com/c-sc/sc?s=BPMA&p=D&yr=0&mn=5&dy=0&i=p68304234748&r=6802
In April of 2007, Benda bought a 57.57% ownership in Shenzhen SiBiona, which produces the cancer drug Gendicine, the first gene therapy medication for cancer available anywhere in the world. In 2004, Gendicine was approved by Chinese officials for use against head and neck cancer, which is also known as squamous cell cancer. The drug is injected once per week for eight weeks. In the Chinese trials, it achieved a complete remission in 64% of the cases and a partial remission in 32% of the patients. Gendicine was originally priced at $362 per injection.
To buy the stake in SiBiono, Benda paid $7.7 million and gave SiBiono 2.1 million shares of Benda stock in return for financial consulting services. Benda also guaranteed that its shares would be worth $3.60 per share within three months after the expiration of the 12-month restriction on selling the shares.
Benda operates three plants in the Hubei Province of China: Benda Ebei, which produces conventional medicines and Traditional Chinese Medicines; Jiangling Benda, which produces active pharmaceutical; and Yidu Benda, which produces bulk chemicals.
INSTITUTIONAL OWNERSHIP
Pope Investments LLC owns 22,337,998 shares accounting for 21.24% of shares outstanding!!
pinksheets.com/edgar/GetFilingHtml
SHARE STRUCTURE
As of August 19, 2009:
Shares Outstanding:105,155,355
Shares Authorized:150,000,000
[img]stockcharts.com/c-sc/sc?s=bpma&p=d&b=5&g=0&id=p86819233489[/img]
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |